BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27158466)

  • 1. Update on the pathogenesis of Scleroderma: focus on circulating progenitor cells.
    Brunasso AM; Massone C
    F1000Res; 2016; 5():. PubMed ID: 27158466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Roles of aberrant endothelial progenitor cells in pathogenesis of systemic sclerosis].
    Kuwana M
    Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(1):17-26. PubMed ID: 23445728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype.
    Mathai SK; Gulati M; Peng X; Russell TR; Shaw AC; Rubinowitz AN; Murray LA; Siner JM; Antin-Ozerkis DE; Montgomery RR; Reilkoff RA; Bucala RJ; Herzog EL
    Lab Invest; 2010 Jun; 90(6):812-23. PubMed ID: 20404807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidimensional Proteomic Approach of Endothelial Progenitors Demonstrate Expression of KDR Restricted to CD19 Cells.
    Guerin CL; Guyonnet L; Goudot G; Revets D; Konstantinou M; Chipont A; Chocron R; Blandinieres A; Khider L; Rancic J; Peronino C; Debuc B; Cras A; Knosp C; Latremouille C; Capel A; Ollert M; Diehl JL; Jansen P; Planquette B; Sanchez O; Gaussem P; Mirault T; Carpentier A; Gendron N; Smadja DM
    Stem Cell Rev Rep; 2021 Apr; 17(2):639-651. PubMed ID: 33205351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum levels of fractalkine and mobilisation of CD34
    Benyamine A; Magalon J; Cointe S; Lacroix R; Arnaud L; Bardin N; Rossi P; Francès Y; Bernard-Guervilly F; Kaplanski G; Harlé JR; Weiller PJ; Berbis P; Braunstein D; Jouve E; Lesavre N; Couranjou F; Dignat-George F; Sabatier F; Paul P; Granel B
    Arthritis Res Ther; 2017 Mar; 19(1):60. PubMed ID: 28320472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide.
    Tourkina E; Bonner M; Oates J; Hofbauer A; Richard M; Znoyko S; Visconti RP; Zhang J; Hatfield CM; Silver RM; Hoffman S
    Fibrogenesis Tissue Repair; 2011 Jul; 4(1):15. PubMed ID: 21722364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay.
    Cutolo M; Soldano S; Montagna P; Trombetta AC; Contini P; Ruaro B; Sulli A; Scabini S; Stratta E; Paolino S; Pizzorni C; Smith V; Brizzolara R
    Arthritis Res Ther; 2018 Jul; 20(1):157. PubMed ID: 30053831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivation of multipotent progenitors from human circulating CD14+ monocytes.
    Seta N; Kuwana M
    Exp Hematol; 2010 Jul; 38(7):557-63. PubMed ID: 20362030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors.
    Timmermans F; Van Hauwermeiren F; De Smedt M; Raedt R; Plasschaert F; De Buyzere ML; Gillebert TC; Plum J; Vandekerckhove B
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1572-9. PubMed ID: 17495235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proangiogenic hematopoietic cells of monocytic origin: roles in vascular regeneration and pathogenic processes of systemic sclerosis.
    Yamaguchi Y; Kuwana M
    Histol Histopathol; 2013 Feb; 28(2):175-83. PubMed ID: 23275301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel population of mesenchymal progenitors with hematopoietic potential originated from CD14 peripheral blood mononuclear cells.
    Hu G; Liu P; Feng J; Jin Y
    Int J Med Sci; 2010 Dec; 8(1):16-29. PubMed ID: 21209798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Fibronectin Levels in Profibrotic CD14
    Rudnik M; Hukara A; Kocherova I; Jordan S; Schniering J; Milleret V; Ehrbar M; Klingel K; Feghali-Bostwick C; Distler O; Błyszczuk P; Kania G
    Front Immunol; 2021; 12():642891. PubMed ID: 34504485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial differentiation potential of human monocyte-derived multipotential cells.
    Kuwana M; Okazaki Y; Kodama H; Satoh T; Kawakami Y; Ikeda Y
    Stem Cells; 2006 Dec; 24(12):2733-43. PubMed ID: 16888284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis.
    Campioni D; Lo Monaco A; Lanza F; Moretti S; Ferrari L; Fotinidi M; La Corte R; Cuneo A; Trotta F
    Haematologica; 2008 Aug; 93(8):1233-7. PubMed ID: 18556411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of circulating progenitor cell mobilization during submaximal exercise.
    Niemiro GM; Parel J; Beals J; van Vliet S; Paluska SA; Moore DR; Burd NA; De Lisio M
    J Appl Physiol (1985); 2017 Mar; 122(3):675-682. PubMed ID: 28082336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial progenitor cells mobilization after maximal exercise according to heart failure severity.
    Kourek C; Karatzanos E; Psarra K; Georgiopoulos G; Delis D; Linardatou V; Gavrielatos G; Papadopoulos C; Nanas S; Dimopoulos S
    World J Cardiol; 2020 Nov; 12(11):526-539. PubMed ID: 33312438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Inflammatory Parameter Levels Negatively Impact Populations of Circulating Stem Cells (CD133+), Early Endothelial Progenitor Cells (CD133+/VEGFR2+), and Fibroblast Growth Factor in Stroke Patients.
    Golab-Janowska M; Paczkowska E; Machalinski B; Kotlega D; Meller A; Safranow K; Wankowicz P; Nowacki P
    Curr Neurovasc Res; 2019; 16(1):19-26. PubMed ID: 30706812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia.
    Massa M; Rosti V; Ramajoli I; Campanelli R; Pecci A; Viarengo G; Meli V; Marchetti M; Hoffman R; Barosi G
    J Clin Oncol; 2005 Aug; 23(24):5688-95. PubMed ID: 16110028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement.
    Trombetta AC; Soldano S; Contini P; Tomatis V; Ruaro B; Paolino S; Brizzolara R; Montagna P; Sulli A; Pizzorni C; Smith V; Cutolo M
    Respir Res; 2018 Sep; 19(1):186. PubMed ID: 30249259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow endothelial progenitors are defective in systemic sclerosis.
    Del Papa N; Quirici N; Soligo D; Scavullo C; Cortiana M; Borsotti C; Maglione W; Comina DP; Vitali C; Fraticelli P; Gabrielli A; Cortelezzi A; Lambertenghi-Deliliers G
    Arthritis Rheum; 2006 Aug; 54(8):2605-15. PubMed ID: 16868984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.